NXGL NEXGEL, Inc: Earnings per share for the last 12 months

NEXGEL Inc (NXGL) - corporate logo

Risks associated with the slow development of the retail network and production scaling are putting pressure on the business, as illustrated by the rolling annual EPS growth chart. The current value of this metric is -78.10. The prospects for NEXGEL, Inc. (NXGL) are based on the growth of B2B orders and e-commerce sales, while its competitive advantage is driven by patented electronic cross-linking hydrogel technology for efficient drug delivery.

NXGL NEXGEL Inc: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/16/2026

Financial and market metric breakdowns for NEXGEL Inc (NXGL)

- market price and analyst price targets:
Initial company analysis:NEXGEL, Inc.
Product sample of NEXGEL, Inc

For an investor assessing the issuer's financial stability, this indicator measures the growth rate of net earnings per share over a rolling year, revealing the actual efficiency of shareholder equity generation while eliminating seasonal distortions. By analyzing the rolling year EPS growth, one can evaluate how the synergy between B2B contracts and retail sales of hydrogels at NEXGEL, Inc. (NXGL) converts into stable profit growth.

Competitor analysis for NEXGEL, Inc.

Net earnings per share for the last four quarters Intuitive Surgical, Inc. ISRG|Danaher Corporation Inc. (DHR) - Earnings per share for the last twelve months|BDX - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months STE|WST (westpharma.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Baxter (BAX)|Earnings per share for the last four quarters MASI|Earnings per share for the last twelve months Stevanato STVN|Net earnings per share (EPS TTM) Teleflex Corp TFX|MMSI: Net earnings per share for the last 12 months|NVST - Net earnings per share (EPS TTM)|ICU Medical Inc (ICUI) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Dentsply Sirona|LMAT (lemaitre.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AtriCure Medical ATRC|Earnings per share for the last twelve months STAAR Surgical (STAA)|ChromaDex - Earnings per share for the last 12 months|ZimVie Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANGO (AngioDynamics Inc)|CERS - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Alpha Teknova Inc TKNO|monogramorthopedics.com (MGRM) - Earnings per share for the last twelve months|STSS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Earnings per share for the last four quarters|Earnings per share for the last twelve months KORU Medical Systems, Inc. (KRMD)|Nyxoah S.A - Earnings per share for the last 12 months|Earnings per share for the last twelve months Microbot Medical Inc. MBOT|Net earnings per share for the trailing year Pro-Dex, Inc.|Zentek Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Elutia ELUT|MLSS (Milestone Scientific Inc.) - Net earnings per share for the last 12 months|RVP: Earnings per share for the last four quarters|HBIO (Harvard Bioscience, Inc.) - Net earnings per share (EPS TTM)|Femasys (FEMY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) MHUA|Net earnings per share for the last four quarters Predictive Oncology Corp|Earnings per share for the last twelve months Callan JMB Inc CJMB|Atrion Corporation Inc. (ATRI) - Net earnings per one share for the last twelve months|neurometrix.com - Net earnings per share (EPS TTM)